197 related articles for article (PubMed ID: 11830480)
1. Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.
Silvestris F; Cafforio P; Tucci M; Dammacco F
Blood; 2002 Feb; 99(4):1305-13. PubMed ID: 11830480
[TBL] [Abstract][Full Text] [Related]
2. Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression.
Silvestris F; Tucci M; Cafforio P; Dammacco F
Blood; 2001 Mar; 97(5):1155-64. PubMed ID: 11222356
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of erythroblast apoptosis by malignant plasma cells: a new pathogenetic mechanism of anemia in multiple myeloma.
Silvestris F; Cafforio P; Grinello D; Dammacco F
Rev Clin Exp Hematol; 2002; Suppl 1():39-46. PubMed ID: 12735214
[TBL] [Abstract][Full Text] [Related]
4. [Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma].
Grzaśko N
Postepy Hig Med Dosw (Online); 2004; 58():364-71. PubMed ID: 15536394
[TBL] [Abstract][Full Text] [Related]
5. Anemia in multiple myeloma: role of deregulated plasma cell apoptosis.
Tucci M; Grinello D; Cafforio P; Silvestris F; Dammacco F
Leuk Lymphoma; 2002 Aug; 43(8):1527-33. PubMed ID: 12400594
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in understanding the pathogenesis of anemia in multiple myeloma.
Silvestris F; Tucci M; Quatraro C; Dammacco F
Int J Hematol; 2003 Aug; 78(2):121-5. PubMed ID: 12953805
[TBL] [Abstract][Full Text] [Related]
7. TRAIL regulates normal erythroid maturation through an ERK-dependent pathway.
Secchiero P; Melloni E; Heikinheimo M; Mannisto S; Di Pietro R; Iacone A; Zauli G
Blood; 2004 Jan; 103(2):517-22. PubMed ID: 12969966
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease.
Silvestris F; Cafforio P; Tucci M; Grinello D; Dammacco F
Br J Haematol; 2003 Jul; 122(1):39-52. PubMed ID: 12823344
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of erythropoiesis by thalidomide in multiple myeloma patients: its influence on FasL, TRAIL and their receptors on erythroblasts.
Grzasko N; Dmoszynska A; Hus M; Soroka-Wojtaszko M
Haematologica; 2006 Mar; 91(3):386-9. PubMed ID: 16531263
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1.
De Maria R; Zeuner A; Eramo A; Domenichelli C; Bonci D; Grignani F; Srinivasula SM; Alnemri ES; Testa U; Peschle C
Nature; 1999 Sep; 401(6752):489-93. PubMed ID: 10519553
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes.
Campioni D; Secchiero P; Corallini F; Melloni E; Capitani S; Lanza F; Zauli G
Am J Pathol; 2005 Feb; 166(2):557-63. PubMed ID: 15681838
[TBL] [Abstract][Full Text] [Related]
12. Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)--mediated cytotoxicity by selective up-regulation of TRAIL-R1.
Di Pietro R; Secchiero P; Rana R; Gibellini D; Visani G; Bemis K; Zamai L; Miscia S; Zauli G
Blood; 2001 May; 97(9):2596-603. PubMed ID: 11313247
[TBL] [Abstract][Full Text] [Related]
13. Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis.
Felli N; Pedini F; Zeuner A; Petrucci E; Testa U; Conticello C; Biffoni M; Di Cataldo A; Winkles JA; Peschle C; De Maria R
J Immunol; 2005 Aug; 175(3):1464-72. PubMed ID: 16034083
[TBL] [Abstract][Full Text] [Related]
14. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis.
Zamai L; Secchiero P; Pierpaoli S; Bassini A; Papa S; Alnemri ES; Guidotti L; Vitale M; Zauli G
Blood; 2000 Jun; 95(12):3716-24. PubMed ID: 10845902
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-induced by TRAIL AND TNF-alpha in human multiple myeloma cells is not blocked by BCL-2.
Gazitt Y; Shaughnessy P; Montgomery W
Cytokine; 1999 Dec; 11(12):1010-9. PubMed ID: 10623426
[TBL] [Abstract][Full Text] [Related]
16. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
Siegmund D; Mauri D; Peters N; Juo P; Thome M; Reichwein M; Blenis J; Scheurich P; Tschopp J; Wajant H
J Biol Chem; 2001 Aug; 276(35):32585-90. PubMed ID: 11384965
[TBL] [Abstract][Full Text] [Related]
17. Stem cell factor prevents Fas-mediated apoptosis of human erythroid precursor cells with Src-family kinase dependency.
Nishio M; Oda A; Koizumi K; Satoh I; Sato Y; Endoh T; Tsutsumi A; Fujihara M; Ikebuchi K; Ikeda H; Koike T; Sawada KI
Exp Hematol; 2001 Jan; 29(1):19-29. PubMed ID: 11164102
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.
Shipman CM; Croucher PI
Cancer Res; 2003 Mar; 63(5):912-6. PubMed ID: 12615702
[TBL] [Abstract][Full Text] [Related]
19. Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma.
Chen Q; Gong B; Mahmoud-Ahmed AS; Zhou A; Hsi ED; Hussein M; Almasan A
Blood; 2001 Oct; 98(7):2183-92. PubMed ID: 11568006
[TBL] [Abstract][Full Text] [Related]
20. Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.
Mitsiades N; Mitsiades CS; Poulaki V; Anderson KC; Treon SP
Blood; 2002 Mar; 99(6):2162-71. PubMed ID: 11877293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
